Stock listing

KRX:302440 SK bioscience Co.,Ltd. (SK바이오사이언스) 주가

Follow SK bioscience Co.,Ltd. into a list and get an email when it puts out news.

Share price · KRX:302440

₩36,300 KRW -150 (-0.4%)

Close on Oct 14, 2026

SK bioscience Co.,Ltd. logo
Ticker
KRX:302440
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
KRX
Currency
KRW

What changed lately

Latest news

SK bioscience Secures Funding to Advance RSV Preventive Antibody Development with RIGHT Foundation Support

Mar 18, 2026

SK bioscience, IDT Biologika and Vaxxas Selected for Next-Generation Influenza Vaccine development Financed by the European Union

Feb 26, 2026

SK bioscience In-Licenses RSV Preventive mAb Candidate from Gates Medical Research Institute

Feb 3, 2026

SK bioscience Initiates International Phase 1/2 Clinical Trial of Universal Vaccine Candidate Targeting Sarbecovirus Family

Jan 28, 2026

SK bioscience, MSD, and Hilleman Laboratories Advance Zaire ebolavirus Vaccine Development with CEPI Funding

Jan 22, 2026

Novavax Reports Third Quarter 2025 Financial Results and Operational Highlights

Nov 6, 2025

Issued by another party

SK bioscience Files for First-in-Human Trial of Universal Coronavirus Vaccine (Pan-sarbecovirus Vaccine) GBP511 Phase 1/2 study in Australia

Oct 15, 2025

SK bioscience Submits IND for Phase 3 Trial of 2-Dose Varicella Vaccine Reflecting Global Standard Shift

Sep 2, 2025

SK bioscience Discusses Further Collaboration with the Gates Foundation to Advance Global Health

Aug 21, 2025

Novavax Reports Second Quarter 2025 Financial Results and Operational Highlights

Aug 6, 2025

Issued by another party

All SK bioscience Co.,Ltd. news

SK bioscience Co.,Ltd. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
6 in the last 12 months · 16 in all · newest Mar 18, 2026 · oldest 2025

Log in to ask 6ix AI your own questions about SK bioscience Co.,Ltd.